locally advanced or metastatic breast cancer
Showing 1 - 12 of 12
Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (SPH4336 Tablets, SPH4336 Tablets Placebo)
Not yet recruiting
- Locally Advanced or Metastatic Breast Cancer
- SPH4336 Tablets
- SPH4336 Tablets Placebo
-
Guangzhou, Guangdong, ChinaAffiliated Cancer Hospital, Sun Yat-sen University
May 8, 2023
Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (SPH4336 Tablets 400mg, SPH4336 Tablets Placebo)
Not yet recruiting
- Locally Advanced or Metastatic Breast Cancer
- SPH4336 Tablets 400mg
- SPH4336 Tablets Placebo
-
Guangzhou, Guangdong, ChinaAffiliated Cancer Hospital, Sun Yat-sen University
Feb 24, 2023
Locally Advanced or Metastatic Breast Cancer Trial in Canada, Israel, United States (Lasofoxifene, Fulvestrant)
Active, not recruiting
- Locally Advanced or Metastatic Breast Cancer
-
Phoenix, Arizona
- +50 more
Oct 24, 2022
Locally Advanced or Metastatic Breast Cancer Trial in Worldwide (Phesgo, Giredestrant, Docetaxel)
Recruiting
- Locally Advanced or Metastatic Breast Cancer
- Phesgo
- +5 more
-
Los Angeles, California
- +21 more
Jul 25, 2022
Resolution of Eribulin-Induced Peripheral Neuropathy
Completed
- Locally Advanced or Metastatic Breast Cancer
-
Amberg, Germany
- +65 more
Jul 12, 2022
Locally Advanced or Metastatic Breast Cancer Trial in China (GB491+ Fulvestrant, Placebo+Fulvestrant)
Recruiting
- Locally Advanced or Metastatic Breast Cancer
- GB491+ Fulvestrant
- Placebo+Fulvestrant
-
Bengbu, Anhui, China
- +53 more
Jun 10, 2022
Breast Tumors, Locally Advanced or Metastatic Breast Cancer Trial (utidelone)
Not yet recruiting
- Breast Neoplasms
- Locally Advanced or Metastatic Breast Cancer
- (no location specified)
May 30, 2022
Fatigue, Locally Advanced or Metastatic Breast Cancer Trial in Germany, Italy, United States (Reparixin, Placebo)
Recruiting
- Fatigue
- Locally Advanced or Metastatic Breast Cancer
- Reparixin
- Placebo
-
Fort Myers, Florida
- +23 more
May 17, 2022
Breast Tumors, Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (Taxane plus Intermittent Capecitabine, Utidelone
Not yet recruiting
- Breast Neoplasms
- Locally Advanced or Metastatic Breast Cancer
- Taxane plus Intermittent Capecitabine
- +3 more
-
Guangzhou, Guangdong, ChinaShusen Wang
Dec 27, 2021
Eribulin in Korean Breast Cancer Participants
Completed
- Locally Advanced or Metastatic Breast Cancer
- Eribulin mesylate
-
Ansan, Korea, Republic of
- +13 more
Jan 24, 2019
Locally Advanced or Metastatic Breast Cancer Trial in New Brunswick, Brisbane, Modena (Ixabepilone, 32 mg/m^2 + Lapatinib, 1000
Terminated
- Locally Advanced or Metastatic Breast Cancer
- Ixabepilone, 32 mg/m^2 + Lapatinib, 1000 mg
- +3 more
-
New Brunswick, New Jersey
- +2 more
Feb 9, 2016